The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells
Open accessAbstract
Abstract. Objectives: More than 50 years ago, we learned that breast cancer cells (and those of many other types of tumour) endogenously synthesize 95% of fatty acids (FAs) de novo, despite having adequate nutritional lipid supply. Today, we know that breast cancer cells benefit from this phenomenon in terms of enhanced cell proliferation, survival, chemoresistance and metastasis. However, the exact role of the major lipogenic enzyme fatty acid synthase (FASN) as cause, correlate or facilitator of breast cancer remains unidentified. Materials and methods: To evaluate a causal effect of FASN‐catalysed endogenous FA biosynthesis in the natural history of breast cancer disease, HBL100 cells (an SV40‐transformed in vitro model for near‐normal gene expression in the breast epithelium), and MCF10A cells (a non‐transformed, near diploid, spontaneously immortalized human mammary epithelial cell line) were acutely forced to overexpress the human FASN gene. Results: Following transient transfection with plasmid pCMV6‐XL4 carrying full‐length human FASN cDNA (gi: NM 004104), HBL100 cells enhanced their endogenous lipid synthesis while acquiring canonical oncogenic properties such as increased size and number of colonies in semisolid (i.e. soft‐agar) anchorage‐independent cultures. Anchorage‐dependent cell proliferation assays in low serum (0.1% foetal bovine serum), MTT‐based assessment of cell metabolic status and cell death ELISA‐based detection of apoptosis‐induced DNA‐histone fragmentation, together revealed that sole activation of endogenous FA biosynthesis was sufficient to significantly enhance breast epithelial cell proliferation and survival. When analysing molecular mechanisms by which acute activation of de novo FA biosynthesis triggered a transformed phenotype, HBL100 cells, transiently transfected with pCMV6‐XL4/FASN, were found to exhibit a dramatic increase in the number of phosphor‐tyrosine (Tyr)‐containing proteins, as detected by 4G10 antiphosphor‐Tyr monoclonal antibody. Phosphor‐Tyr‐specific antibodies recognizing the phosphorylation status of either the 1173 Tyr residue of epidermal growth factor receptor (HER1) or the 1248 Tyr residue of HER2, further revealed that FASN‐induced Tyr‐phosphorylation at ∼180 kDa region mainly represented that of these key members of the HER (erb B) network, which remained switched‐off in mock‐transfected HBL100 cells. ELISA and immunoblotting procedures demonstrated that FASN overactivation significantly increased (> 200%) expression levels of epidermal growth factor receptor and HER2 proteins in HBL100 cells. Proteome Profiler™ antibody arrays capable of simultaneously detecting relative levels of phosphorylation of 42 phospho‐receptor Tyr‐kinases (RTKs) confirmed that acute activation of endogenous FA biosynthesis specifically promoted hyper‐Tyr‐phosphorylation of HER1 and HER2 in MCF10A cells. This FASN‐triggered HER1/HER2‐breast cancer‐like phenotype was specifically inhibitable either by FASN inhibitor C75 or by Tyr‐kinase inhibitors (TKIs) gefitinib (Iressa™) and lapatinib (Tykerb™) but not by chemotherapeutic agents such as cisplatin. Transient overexpression of FASN dramatically increased HBL100 breast epithelial cells’ sensitivity to cytotoxic effects of C75, gefitinib and lapatinib (∼8, 10 and > 15 times, respectively), while significantly decreasing (∼3 times) cisplatin efficacy. Conclusions: Although we cannot definitely establish FASN as a novel oncogene in breast cancer, this study reveals for the first time that exacerbated endogenous FA biosynthesis in non‐cancerous epithelial cells is sufficient to induce a cancer‐like phenotype functionally dependent on the HER1/HER2 duo. These findings may perhaps radically amend our current perspective of endogenously synthesized fat, as on its own, it appears to actively increase signal‐to‐noise ratio in the HER1/HER2‐driven progression of human breast epithelial cells towards malignancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Fatty acid synthesis: a potential selective target for antineoplastic therapy
Kuhajda, F. P., Jenner, K., Wood, F. D., Hennigar, R. A., Jacobs, L. B., Dick, J. D., & Pasternack, G. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6379 · Cited by 705 · cited 1×
“Despite these data, the endogenous FA pathway did not become a focus of clinical interest as a means to treat or diagnose human cancer until the early 1990s, when Kuhajda and colleagues unambiguously identified through sequence homology and enzymology the Oncogenic Antigen-519 (OA-519) – a prognostic molecule found in…”
Background�ber den Stoffwechsel der Carcinomzelle
Warburg, O. (1924) · Die Naturwissenschaften · doi:10.1007/bf01504608 · Cited by 631
Signal transduction and oncogenesis by ErbB/HER receptors
Marmor, M. D., Skaria, K. B., & Yarden, Y. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.06.002 · Cited by 389 · cited 2×
“Because the process of malignant transformation in many cancers may depend on the abnormal activation of ligands, receptors and signal transduction cascades that function as part of the HER-(Tyr-kinase) axis (Olayioye 2001; Yarden & Sliwkowski 2001; Gross et al. 2004; Marmor et al. 2004; Citri &”
BackgroundMenendez, J., & Lupu, R. (2006) · Current Pharmaceutical Biotechnology · doi:10.2174/138920106779116900 · Cited by 113 · cited 6×
“…is commonly viewed as a mere (down-stream) manifestation of early and common deregulation of (up-stream) regulatory circuits (e.g. hormones/growth factors hormone receptors/growth factor receptors lipogenic transcription factors lipogenic genes) (Kuhajda 2006; Menendez & Lupu 2006; Swinnen et al .”
BackgroundInfluentialSelf-citation
Cited by
Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis
Nomura, D. K., Long, J. Z., Niessen, S., Hoover, H. S., Ng, S.-W., & Cravatt, B. F. (2010) · Cell · doi:10.1016/j.cell.2009.11.027 · Cited by 1,002
Rysman, E., Brusselmans, K., Scheys, K., Timmermans, L., Derua, R., Munck, S., Van Veldhoven, P. P., Waltregny, D., Daniëls, V. W., Machiels, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3871 · Cited by 721
Fatty Acid Synthase As a Potential Therapeutic Target in Cancer
Flavin, R., Peluso, S., Nguyen, P. L., & Loda, M. (2010) · Future Oncology · doi:10.2217/fon.10.11 · Cited by 545
Metformin in Cancer Treatment and Prevention
Morales, D. R., & Morris, A. D. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-062613-093128 · Cited by 484
Fatty Acid Synthase: An Emerging Target in Cancer
Fhu, C. W., & Ali, A. (2020) · Molecules · doi:10.3390/molecules25173935 · Cited by 392
Metadata
- Authors
- Vazquez‐Martin, A., Colomer, R., Brunet, J., Lupu, R., & Menendez, J. A.
- Venue
- Cell Proliferation
- Publisher
- Wiley
- Published
- 2008-01-16
- Volume
- 41
- Issue
- 1
- Pages
- 59-85
- ISSN
- 0960-7722 (ISSN-L)
- 1365-2184
- OpenAlex
- W2121369716
- Cited by
- 199
- References
- 5
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells. https://app.cochat.ai/papers/10.1111/j.1365-2184.2007.00498.x
- The paper
- Vazquez‐Martin, A., Colomer, R., Brunet, J., Lupu, R., & Menendez, J. A. (2008). Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells. Cell Proliferation. https://doi.org/10.1111/j.1365-2184.2007.00498.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.